Search

everythinglearnresearchcommunity

for

Search:↓

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

Large prostates link to more hair loss.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Dosing time affects finasteride's effectiveness and safety in rats.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Finasteride treats hair loss and reduces prostate cancer risk.

Vertex pattern hair loss linked to higher prostate cancer risk.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Certain natural compounds called terpenes may help prevent prostate cancer.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Dutasteride and finasteride affect different cell types differently.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Physical activity, height, and smoking affect prostate cancer risk.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.